Atheroprotective CD40-TRAF6 inhibitors: translational pipeline towards a clinical application

27 August 2023 (14:15 - 15:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Venetia Bazioti

Ludwig Maximilians University, Munich (Germany)

7 More presentations in this session

Presentation thumbnail

Characterization of AT-02, a pan-amyloid-binding peptide fusion immunoglobulin with high binding potency, complement activation, and immune cell stimulation

Professor J. Wall (Knoxville, US)

Abstract Slides Video

Presentation thumbnail

Dapagliflozin downregulates G protein-coupled receptor Kinase-2 and upregulates regulator of g protein signaling-4 in adrenals to exert sympatholysis in heart failure

Associate Professor A. Lymperopoulos (Fort Lauderdale, US)

Abstract Slides Video

Presentation thumbnail

Effective cardiac mRNA delivery using lipid nanoparticles

Ms M. Labonia (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

HS135, a novel activin and GDF trap, is highly efficacious in preclinical models of pulmonary hypertension and obesity-associated heart failure with preserved ejection fraction

Doctor J. Schoelermann (Montreal, CA)

Abstract Slides Video

Presentation thumbnail

Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis

Doctor L. Xu (Shanghai, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Therapeutic strategies to combat vascular disease

The Event

Event poster

ESC Congress 2023

27 August 2023 14:15 CET

You may be interested in

Congress Presentation

Immune cell communication in plaque: checkpoints as immunotherapy targets

Congress Session

Novel targets for treatment of atherosclerosis

Congress Session

Late-Breaking Basic & Translational Science

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources